* Pluristem completes enrollment of 150 patients in phase ii
intermittent claudication trial
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1…
The post BRIEF-Pluristem completes enrollment of 150 patients in phase II intermittent claudication trial appeared first on NASDAQ.